Pulmonary Hypertension Trial, Recruiting NCT06862934 Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano Condition: Pulmonary Hypertension
Back to Pulmonary Hypertension

Pulmonary Hypertension Trial, Recruiting

NCT06862934
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Your cancer has been confirmed as intrahepatic cholangiocarcinoma (a type of bile duct cancer inside the liver) through a biopsy
  • This is either a new diagnosis or the cancer has come back at least 6 months after surgery to remove it
  • A specialist surgical team has determined that surgery to remove the tumor is not possible, either because of where the tumor is located or because of an existing liver condition
  • You are between 18 and 70 years old
  • The cancer has not grown into the major blood vessels of the liver in a way that cannot be explained by the tumor pressing from the outside (confirm with trial site)
  • The cancer has not spread outside the liver
  • Your cancer has been stable for at least 6 months
  • A specific blood marker called CA 19-9 is below 200 u/ml at the time of being listed for a transplant, provided you do not have jaundice
  • You are healthy enough to undergo a liver transplant, with no medical or surgical reasons preventing it
  • You are in good general health and able to carry out daily activities, with little or no limitations (ECOG score of 0 or 1)
  • You have not had any other cancer in the past 5 years and do not currently have another cancer
  • You are willing and able to give written consent to participate

Who may not be able to join:

  • Your cholangiocarcinoma is located at the junction outside the liver (hilar) or further down the bile duct (distal), rather than inside the liver
  • Your cancer got worse or progressed while receiving chemotherapy and/or radiation therapy, as measured by standard medical assessment tools
  • There is evidence that the cancer has spread to lymph nodes
  • There is evidence that the cancer has spread to other parts of the body outside the liver
  • The cancer has previously spread outside the liver at any point
  • You currently have or have had another cancer within the past 5 years
  • You have substance use issues, or medical, mental health, or social circumstances that could interfere with taking part in the study
  • The trial doctors have any other concern that means it would not be appropriate for you to take part (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0223902760

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Registry
ClinicalTrials.gov
Start date
20 March 2025
Est. completion
31 December 2027

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

3-year overall survival vs unresectable patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov